BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 21078186)

  • 1. Assessing karyotype precision by microarray-based comparative genomic hybridization in the myelodysplastic/myeloproliferative syndromes.
    Slovak ML; Smith DD; Bedell V; Hsu YH; O'Donnell M; Forman SJ; Gaal K; McDaniel L; Schultz R; Ballif BC; Shaffer LG
    Mol Cytogenet; 2010 Nov; 3():23. PubMed ID: 21078186
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Microarray-based comparative genomic hybridization of cancer targets reveals novel, recurrent genetic aberrations in the myelodysplastic syndromes.
    Kolquist KA; Schultz RA; Furrow A; Brown TC; Han JY; Campbell LJ; Wall M; Slovak ML; Shaffer LG; Ballif BC
    Cancer Genet; 2011 Nov; 204(11):603-28. PubMed ID: 22200086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical significance of previously cryptic copy number alterations and loss of heterozygosity in pediatric acute myeloid leukemia and myelodysplastic syndrome determined using combined array comparative genomic hybridization plus single-nucleotide polymorphism microarray analyses.
    Koh KN; Lee JO; Seo EJ; Lee SW; Suh JK; Im HJ; Seo JJ
    J Korean Med Sci; 2014 Jul; 29(7):926-33. PubMed ID: 25045224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based genomic diagnosis characterized chromosomal and cryptic imbalances in 30 elderly patients with myelodysplastic syndrome and acute myeloid leukemia.
    Bajaj R; Xu F; Xiang B; Wilcox K; Diadamo AJ; Kumar R; Pietraszkiewicz A; Halene S; Li P
    Mol Cytogenet; 2011 Jan; 4():3. PubMed ID: 21251322
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genomic aberrations of myeloproliferative and myelodysplastic/myeloproliferative neoplasms in chronic phase and during disease progression.
    Hahm C; Huh HJ; Mun YC; Seong CM; Chung WS; Huh J
    Int J Lab Hematol; 2015 Apr; 37(2):181-9. PubMed ID: 24845343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High rates of submicroscopic aberrations in karyotypically normal acute lymphoblastic leukemia.
    Othman MA; Melo JB; Carreira IM; Rincic M; Glaser A; Grygalewicz B; Gruhn B; Wilhelm K; Rittscher K; Meyer B; Silva ML; de Jesus Marques Salles T; Liehr T
    Mol Cytogenet; 2015; 8():45. PubMed ID: 26136832
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The assessment of array comparative genomic hybridization in complex karyotype analyses.
    Bystřická D; Zemanová Z; Březinová J; Gančarčíková M; Grosová L; Sárová I; Izáková S; Berková A; Michalová K
    Folia Biol (Praha); 2010; 56(5):223-30. PubMed ID: 21138655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytogenetic and genomic characterization of cell line ARH77.
    Parker H; Cheung KL; Robinson HM; Harrison CJ; Strefford JC
    Cancer Genet Cytogenet; 2008 Feb; 181(1):40-5. PubMed ID: 18262052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Three novel cytogenetically cryptic EVI1 rearrangements associated with increased EVI1 expression and poor prognosis identified in 27 acute myeloid leukemia cases.
    Haferlach C; Bacher U; Grossmann V; Schindela S; Zenger M; Kohlmann A; Kern W; Haferlach T; Schnittger S
    Genes Chromosomes Cancer; 2012 Dec; 51(12):1079-85. PubMed ID: 22887804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical Applications of Chromosomal Microarray Testing in Myeloid Malignancies.
    Ronaghy A; Yang RK; Khoury JD; Kanagal-Shamanna R
    Curr Hematol Malig Rep; 2020 Jun; 15(3):194-202. PubMed ID: 32382988
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromothripsis Is a Recurrent Genomic Abnormality in High-Risk Myelodysplastic Syndromes.
    Abáigar M; Robledo C; Benito R; Ramos F; Díez-Campelo M; Hermosín L; Sánchez-Del-Real J; Alonso JM; Cuello R; Megido M; Rodríguez JN; Martín-Núñez G; Aguilar C; Vargas M; Martín AA; García JL; Kohlmann A; Del Cañizo MC; Hernández-Rivas JM
    PLoS One; 2016; 11(10):e0164370. PubMed ID: 27741277
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
    Peterson JF; Aggarwal N; Smith CA; Gollin SM; Surti U; Rajkovic A; Swerdlow SH; Yatsenko SA
    Oncotarget; 2015 Aug; 6(22):18845-62. PubMed ID: 26299921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microarray-based genomic profiling and in situ hybridization on fibrotic bone marrow biopsies for the identification of numerical chromosomal abnormalities in myelodysplastic syndrome.
    Stevens-Kroef MJ; Hebeda KM; Verwiel ET; Kamping EJ; van Cleef PH; Kuiper RP; Groenen PJ
    Mol Cytogenet; 2015; 8():33. PubMed ID: 26023320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-resolution genome-wide array-based comparative genome hybridization reveals cryptic chromosome changes in AML and MDS cases with trisomy 8 as the sole cytogenetic aberration.
    Paulsson K; Heidenblad M; Strömbeck B; Staaf J; Jönsson G; Borg A; Fioretos T; Johansson B
    Leukemia; 2006 May; 20(5):840-6. PubMed ID: 16498392
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clonal heterogeneity in childhood myelodysplastic syndromes--challenge for the detection of chromosomal imbalances by array-CGH.
    Praulich I; Tauscher M; Göhring G; Glaser S; Hofmann W; Feurstein S; Flotho C; Lichter P; Niemeyer CM; Schlegelberger B; Steinemann D
    Genes Chromosomes Cancer; 2010 Oct; 49(10):885-900. PubMed ID: 20589934
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic imbalances are confined to non-proliferating cells in paediatric patients with acute myeloid leukaemia and a normal or incomplete karyotype.
    Ballabio E; Regan R; Garimberti E; Harbott J; Bradtke J; Teigler-Schlegel A; Biondi A; Cazzaniga G; Giudici G; Wainscoat JS; Boultwood J; Bridger JM; Knight SJ; Tosi S
    PLoS One; 2011; 6(6):e20607. PubMed ID: 21694761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of chronic lymphocytic leukemia by BAC-based microarray analysis.
    Schultz RA; Delioukina M; Gaal K; Bedell V; Smith DD; Forman SJ; McDaniel LD; Ballif BC; Shaffer LG; Slovak ML
    Mol Cytogenet; 2011 Feb; 4(1):4. PubMed ID: 21291569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Incidence and significance of cryptic chromosome aberrations detected by fluorescence in situ hybridization in acute myeloid leukemia with normal karyotype.
    Cuneo A; Bigoni R; Cavazzini F; Bardi A; Roberti MG; Agostini P; Tammiso E; Ciccone N; Mancini M; Nanni M; De Cuia R; Divona M; La Starza R; Crescenzi B; Testoni N; Rege Cambrin G; Mecucci C; Lo Coco F; Saglio G; Castoldi G
    Leukemia; 2002 Sep; 16(9):1745-51. PubMed ID: 12200689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A genome assembly-integrated dog 1 Mb BAC microarray: a cytogenetic resource for canine cancer studies and comparative genomic analysis.
    Thomas R; Duke SE; Karlsson EK; Evans A; Ellis P; Lindblad-Toh K; Langford CF; Breen M
    Cytogenet Genome Res; 2008; 122(2):110-21. PubMed ID: 19096206
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of Array Comparative Genomic Hybridization for the Diagnosis of DiGeorge Syndrome in Saudi Arabian Population.
    Bahamat AA; Assidi M; Lary SA; Almughamsi MM; Peer Zada AA; Chaudhary A; Abuzenadah A; Abu-Elmagd M; Al-Qahtani M
    Cytogenet Genome Res; 2018; 154(1):20-29. PubMed ID: 29455205
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.